Related Experiment Videos
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral
Christina L Liquori1, Michel J Berg, Adrian M Siegel
1Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. Mutations in the gene KRIT1 are responsible for type 1 CCM (CCM1). We report that a novel gene, MGC4607, exhibits eight different mutations in nine families with type 2 CCM (CCM2). MGC4607, similar to the KRIT1 binding partner ICAP1alpha, encodes a protein with a phosphotyrosine-binding domain. This protein may be part of the complex pathway of integrin signaling that, when perturbed, causes abnormal vascular morphogenesis in the brain, leading to CCM formation.